首页> 外国专利> MONOCLONAL ANTIBODY SPECIFICALLY BINDING HUMAN AND MONKEY CD38 ANTIGEN, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

MONOCLONAL ANTIBODY SPECIFICALLY BINDING HUMAN AND MONKEY CD38 ANTIGEN, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

机译:单克隆抗体特异性结合人和猴CD38抗原,其制备方法及其应用

摘要

The invention herein provides a monoclonal antibody that specifically binds to human and monkey CD38 antigens or a derivative thereof, comprising antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody light chain variable region having amino acid sequences as set forth in SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, respectively; and antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody heavy chain variable region having amino acid sequences as set forth in SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10, respectively. The antibody or derivative thereof can be used as a component of a pharmaceutical composition or prepared into a suitable pharmaceutical preparation, administered alone or combined with other therapeutic means such as chemotherapy drugs, for treating tumors with positive CD38 expression, such as human myeloma and human lymphoma.
机译:本发明提供一种单克隆抗体,其特异性结合人和猴CD38抗原或其衍生物,其包含抗体轻链可变区的抗原互补确定区域CDR1,CDR2和CDR3,其具有SEQ ID NO中所述的氨基酸序列:3,SEQ ID NO:4和SEQ ID NO:5分别;抗体重链可变区的抗原重链可变区的CDR1,CDR2和CDR3分别分别在SEQ ID NO:8,SEQ ID NO:9和SEQ ID NO:10中列出的氨基酸序列的抗体重链可变区的CDR1,CDR2和CDR3的CDR1,CDR2和CDR3。其抗体或衍生物可用作药物组合物的组分,或者制备单独给药或与其他治疗药物如化疗药物组合的合适的药物制剂中制备,用于治疗阳性CD38表达,例如人骨髓瘤和人类的肿瘤淋巴瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号